SDC1 and Miyoshi myopathy: DCs pulsed with MAGE, cancer-testis antigen, sDickkof-1, CD138, CS1, XBP1, survivin, and BCMA induce antigen-specific CTLs targeting MM cells in vitro, and several vaccines have been tested in clinical trials [192,193,194,195,196,197].